LKST
Leukosite Inc
Biopharmaceutical company developing monoclonal antibody therapies for oncology and inflammatory diseases; acquired by Millennium Pharmaceuticals in December 1999
CUSIP: 52728R102HealthcareUS1 holder
Recent Activity
1999Q3
1 buy
+15.0K shares
+15.0K shares